Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Literature
1.
Kamdar BB, Tergas AI, Mateen FJ et al (2013) Night-shift work and risk of breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 138:291–301PubMedCrossRef
2.
Stevens RG, Hansen J, Costa G et al (2011) Considerations of circadian impact for defining ‘shift work’ in cancer studies: IARC Working Group Report. Occup Environ Med 68:154–162PubMedCrossRef
3.
Schernhammer ES, Laden F, Speizer FE et al (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst 93:1563–1568PubMedCrossRef
4.
Schernhammer ES, Kroenke CH, Laden F et al (2006) Night work and risk of breast cancer. Epidemiology 17:108–111PubMedCrossRef
5.
Hansen J (2001) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12:74–77PubMedCrossRef
6.
Li W (2011) Magnetic fields, night shift work and the risk of breast cancer among female textile workers in Shanghai, China. ProQuest Dissertations and Theses, University of Washington School of Public Health
7.
Schwartzbaum J, Ahlbom A, Feychting M (2007) Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 33:336–343PubMedCrossRef
8.
O’Leary ES, Schoenfeld ER, Stevens RG et al (2006) Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol 164:358–366PubMedCrossRef
9.
Menegaux F, Truong T, Anger A (2013) Night work and breast cancer: a population-based case-control study in France (the CECILE study). Int J Cancer 132:924–931PubMedCrossRef
10.
Hansen J, Lassen CF (2012) Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med 69:551–556PubMedCrossRef
11.
Hansen J, Stevens RG (2012) Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer 48:1722–1729PubMedCrossRef
12.
Knutsson A, Alfredsson L, Karlsson B et al (2013) Breast cancer among shift workers: results of the WOLF longitudinal cohort study. Scand J Work Environ Health 39:170–177PubMedCrossRef
13.
1.
Stevens RG, Hansen J (2013) Letter to Editor re: Night-shift work and risk of breast cancer Biren B. Kamdar et al. Breast Cancer Res Treat
2.
Megdal SP, Kroenke CH, Laden F et al (2005) Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 41:2023–2032PubMedCrossRef
3.
Kamdar BB, Tergas AI, Mateen FJ et al (2013) Night-shift work and risk of breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 138:291–301PubMedCrossRef
4.
Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012PubMedCrossRef
5.
Schernhammer ES, Laden F, Speizer FE et al (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst 93:1563–1568PubMedCrossRef
6.
Schernhammer ES, Kroenke CH, Laden F et al (2006) Night work and risk of breast cancer. Epidemiology 17:108–111PubMedCrossRef
7.
O’Leary ES, Schoenfeld ER, Stevens RG et al (2006) Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol 164:358–366PubMedCrossRef
8.
Jia Y, Lu Y, Wu K et al (2013) Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies. Cancer Epidemiol 37(3):197–206PubMedCrossRef
9.
Schwartzbaum J, Ahlbom A, Feychting M (2007) Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 33:336–343PubMedCrossRef
Metadata
Title
Letter to the Editor, Re: Night-shift work and risk of breast cancer (Kamdar et al., doi:10.1007/s10549-013-2433-1)
Authors
Richard Stevens
Johnni Hansen
Publication date
01-05-2013
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2013
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2536-8

Other articles of this Issue 1/2013

Breast Cancer Research and Treatment 1/2013 Go to the issue

Clinical trial

CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy

Clinical trial

The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial

Clinical trial

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer

Epidemiology

Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient–provider relationship

Epidemiology

Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study

Preclinical study

DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits